New York, NY, United States of America

Aaron P Perlmutter

This inventor holds 9 USPTO granted patents. Top assignees: Thermatrx, Inc., Ams Research Corporation, Boston Scientific Scimed, Inc.. Active years: 2001-2011.


% Patents Active = 44.4

Average Co-Inventor Count = 5.0

ph-index = 9

Forward Citations = 659(Granted Patents)


Company Filing History:


Years Active: 2001-2011

Loading Chart...
9 patents (USPTO):Explore Patents

Title: The Innovations of Aaron P. Perlmutter

Introduction

Aaron P. Perlmutter is a notable inventor based in New York, NY (US). He has made significant contributions to the field of medical devices, particularly in the treatment of urinary retention. With a total of 9 patents to his name, Perlmutter's work has had a meaningful impact on patient care.

Latest Patents

One of his latest patents involves a urethral prosthesis designed to provide relief from urinary retention. This innovative device features first and second tubular elements with an interposed bridge segment. Additionally, a valve can be incorporated into the second tubular element to control the flow of urine, enhancing its functionality and effectiveness.

Career Highlights

Throughout his career, Perlmutter has worked with several companies, including Thermatrx, Inc. and Scimed Life Systems, Inc. His experience in these organizations has allowed him to develop and refine his inventions, contributing to advancements in medical technology.

Collaborations

Some of his notable coworkers include Charles F. Manker and Theron N. Schaefermeyer. Their collaboration has likely fostered an environment of innovation and creativity, leading to the development of groundbreaking medical solutions.

Conclusion

Aaron P. Perlmutter's contributions to the field of medical devices, particularly in treating urinary retention, showcase his dedication to improving patient outcomes. His innovative spirit and collaborative efforts continue to inspire advancements in healthcare technology.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…